Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 975

1.

[Weight variation in users of the levonorgestrel-releasing intrauterine system, of the copper IUD and of medroxyprogesterone acetate in Brazil].

Yela DA, Monteiro IM, Bahamondes LG, Del Castillo S, Bahamondes MV, Fernandes A.

Rev Assoc Med Bras. 2006 Jan-Feb;52(1):32-6. Epub 2006 Apr 10. Portuguese.

PMID:
16622536
[PubMed - indexed for MEDLINE]
Free Article
2.

Body weight and composition in users of levonorgestrel-releasing intrauterine system.

Dal'Ava N, Bahamondes L, Bahamondes MV, de Oliveira Santos A, Monteiro I.

Contraception. 2012 Oct;86(4):350-3. doi: 10.1016/j.contraception.2012.01.017. Epub 2012 Mar 23.

PMID:
22445431
[PubMed - indexed for MEDLINE]
3.

Weight change at 12 months in users of three progestin-only contraceptive methods.

Vickery Z, Madden T, Zhao Q, Secura GM, Allsworth JE, Peipert JF.

Contraception. 2013 Oct;88(4):503-8. doi: 10.1016/j.contraception.2013.03.004. Epub 2013 Mar 18.

PMID:
23582238
[PubMed - indexed for MEDLINE]
4.

Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years.

Bahamondes L, Del Castillo S, Tabares G, Arce XE, Perrotti M, Petta C.

Contraception. 2001 Oct;64(4):223-5.

PMID:
11747871
[PubMed - indexed for MEDLINE]
5.

A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.

Viola AS, Castro S, Bahamondes MV, Fernandes A, Viola CF, Bahamondes L.

Contraception. 2011 Nov;84(5):e31-7. doi: 10.1016/j.contraception.2011.06.012. Epub 2011 Aug 10.

PMID:
22018135
[PubMed - indexed for MEDLINE]
6.

Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system.

Bahamondes MV, Monteiro I, Castro S, Espejo-Arce X, Bahamondes L.

Hum Reprod. 2010 May;25(5):1158-64. doi: 10.1093/humrep/deq043. Epub 2010 Feb 25.

PMID:
20185512
[PubMed - indexed for MEDLINE]
Free Article
7.

Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.

Sivin I, Stern J, Diaz S, Pavéz M, Alvarez F, Brache V, Mishell DR Jr, Lacarra M, McCarthy T, Holma P, et al.

Am J Obstet Gynecol. 1992 Apr;166(4):1208-13.

PMID:
1566771
[PubMed - indexed for MEDLINE]
8.
9.

A cross-sectional study of the forearm bone density of long-term users of levonorgestrel-releasing intrauterine system.

Bahamondes L, Espejo-Arce X, Hidalgo MM, Hidalgo-Regina C, Teatin-Juliato C, Petta CA.

Hum Reprod. 2006 May;21(5):1316-9. Epub 2005 Dec 22.

PMID:
16373404
[PubMed - indexed for MEDLINE]
Free Article
10.

Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.

Sivin I, Stern J, Diaz J, Diaz MM, Faundes A, el Mahgoub S, Diaz S, Pavez M, Coutinho E, Mattos CE, et al.

Contraception. 1987 Mar;35(3):245-55.

PMID:
3111785
[PubMed - indexed for MEDLINE]
11.

Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive.

Pantoja M, Medeiros T, Baccarin MC, Morais SS, Bahamondes L, Fernandes AM.

Contraception. 2010 Feb;81(2):107-11. doi: 10.1016/j.contraception.2009.07.008. Epub 2009 Dec 2.

PMID:
20103446
[PubMed - indexed for MEDLINE]
12.

Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.

Rönnerdag M, Odlind V.

Acta Obstet Gynecol Scand. 1999 Sep;78(8):716-21.

PMID:
10468065
[PubMed - indexed for MEDLINE]
13.

Selection and performance of the levonorgestrel-releasing intrauterine system.

Lähteenmäki P, Bardin CW, Elomaa K, Haukkamaa M, Kivijärvi A, Kuukankorpi A, Venhola M, Tuominen J.

Acta Obstet Gynecol Scand Suppl. 1997;164:69-74.

PMID:
9225643
[PubMed - indexed for MEDLINE]
14.
15.

The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.

Pakarinen P, Lähteenmäki P, Rutanen EM.

Acta Obstet Gynecol Scand. 1999 May;78(5):423-8.

PMID:
10326889
[PubMed - indexed for MEDLINE]
16.

[The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].

Imperato F, Perniola G, Mossa B, Marziani R, Perniola F, Stragapede B, Napolitano C.

Minerva Ginecol. 2002 Jun;54(3):271-8. Italian.

PMID:
12063443
[PubMed - indexed for MEDLINE]
17.

Assessment of menstrual blood loss in Brazilian users of the frameless copper-releasing IUD with copper surface area of 330 mm2 and the frameless levonorgestrel-releasing intrauterine system.

Andrade AT, Souza JP, Andrade GN, Rowe PJ, Wildemeersch D.

Contraception. 2004 Aug;70(2):173-7.

PMID:
15288225
[PubMed - indexed for MEDLINE]
18.

Comparison of the effects of the levonorgestrel-releasing intrauterine system (Mirena) and depot-medroxyprogesterone acetate (Depo-Provera) on subendometrial microvascularisation and uterine artery blood flow.

Dane B, Akca A, Dane C, Evcimen S, Cetin A.

Eur J Contracept Reprod Health Care. 2009 Jun;14(3):240-4. doi: 10.1080/13625180902850047.

PMID:
19565422
[PubMed - indexed for MEDLINE]
19.

Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.

Luukkainen T, Toivonen J.

Contraception. 1995 Nov;52(5):269-76. Review.

PMID:
8585882
[PubMed - indexed for MEDLINE]
20.

Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.

Xiao B, Zeng T, Wu S, Sun H, Xiao N.

Contraception. 1995 Jun;51(6):359-65.

PMID:
7554977
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk